Hypermutation in human cancer genomes: Footprints and mechanisms

Nature Reviews Cancer

Volumn 14, Issue 12, 2014, Pages 786-800

  Roberts, Steven A ^a,b   Gordenin, Dmitry A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; DNA DAMAGE; DNA REPLICATION; DNA REPLICATION TIMING; DNA STRAND; DNA SYNTHESIS; EXCISION REPAIR; EXOME; GENE MUTATION; HUMAN; MUTAGENESIS; MUTATIONAL ANALYSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; TUMOR GENE; DNA REPAIR; GENE DOSAGE; GENETICS; HUMAN GENOME; MUTATION; NEOPLASM;

DNA DAMAGE; DNA REPAIR; GENE DOSAGE; GENOME, HUMAN; HUMANS; MUTATION; NEOPLASMS;

EID: 84925497848     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3816     Document Type: Review

References (170)

1. Aaltonen, L. A. et al. Clues to the pathogenesis of familial colorectal cancer. Science 260, 812-816 (1993
2. Cleaver, J. E. & Crowley, E. UV damage, DNA repair and skin carcinogenesis. Frontiers Biosci. 7, D1024-D1043 (2002
3. Hart, R. W., Setlow, R. B. & Woodhead, A. D. Evidence That Pyrimidine Dimers in DNA Can Give Rise to Tumors. Proc. Natl Acad. Sci. USA 74, 5574-5578 (1977
4. Hecht, S. S. Progress and challenges in selected areas of tobacco carcinogenesis. Chem. Res. Toxicol. 21, 160-171 (2008
5. Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D. & Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363, 558-561 (1993
6. Parsons, R. et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 75, 1227-1236 (1993
7. Cunningham, J. M. et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 58, 3455-3460 (1998
8. Fox, E. J., Prindle, M. J. & Loeb, L. A. Do mutator mutations fuel tumorigenesis?. Cancer Metastasis Rev. 32, 353-361 (2013
9. Fox, E. J., Beckman, R. A. & Loeb, L. A. Reply: Is There Any Genetic Instability in Human Cancer?. DNA Repair 9, 859-860 (2010
10. Shibata, D. & Lieber, M. R. Is there any genetic instability in human cancer?. DNA Repair 9, 858; discussion 859-860 (2010
11. Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415-421 (2013
12. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-Associated genes. Nature 499, 214-218 (2013
13. Loeb, L. A., Springgate, C. F. & Battula, N. Errors in DNA replication as a basis of malignant changes. Cancer Res. 34, 2311-2321 (1974
14. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012
15. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315-322 (2014
16. Nagarajan, N. et al. Whole-genome reconstruction and mutational signatures in gastric cancer. Genome Biol. 13, R115 (2012
17. Pugh, T. J. et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488, 106-110 (2012
18. Welch, J. S. et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 150, 264-278 (2012
19. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068 (2008
20. Benzer, S. & Freese, E. Induction of Specific Mutations with 5 Bromouracil. Proc. Natl Acad. Sci. USA 44, 112-119 (1958
21. Rogozin, I. B. & Pavlov, Y. I. Theoretical analysis of mutation hotspots and their DNA sequence context specificity. Mutat. Res. 544, 65-85 (2003
22. Pfeifer, G. P., You, Y. H. & Besaratinia, A. Mutations induced by ultraviolet light. Mutat. Res. 571, 19-31 (2005
23. Sage, E. Distribution and repair of photolesions in DNA: genetic consequences and the role of sequence context. Photochem. Photobiol. 57, 163-174 (1993
24. De, S. & Babu, M. M. A time-invariant principle of genome evolution. Proc. Natl Acad. Sci. USA 107, 13004-13009 (2010
25. Drier, Y. et al. Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability. Genome Res. 23, 228-235 (2013
26. Hicks, W. M., Kim, M. & Haber, J. E. Increased mutagenesis and unique mutation signature associated with mitotic gene conversion. Science 329, 82-85 (2010
27. Malkova, A. & Haber, J. E. Mutations arising during repair of chromosome breaks. Annu. Rev. Genet. 46, 455-473 (2012
28. Deem, A. et al. Break-induced replication is highly inaccurate. PLoS Biol. 9, e1000594 (2011
29. Shee, C., Gibson, J. L. & Rosenberg, S. M. Two mechanisms produce mutation hotspots at DNA breaks in Escherichia coli. Cell Rep. 2, 714-721 (2012
30. Burch, L. H. et al. Damage-induced localized hypermutability. Cell Cycle 10, 1073-1085 (2011)
31. Chan, K. et al. Base damage within single-strand DNA underlies in vivo hypermutability induced by a ubiquitous environmental agent. PLoS Genet. 8, e1003149 (2012
32. Roberts, S. A. et al. Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Mol. Cell 46, 424-435 (2012
33. Yang, Y., Gordenin, D. A. & Resnick, M. A. A single-strand specific lesion drives MMS-induced hyper-mutability at a double-strand break in yeast. DNA Repair 9, 914-921 (2010
34. Yang, Y., Sterling, J., Storici, F., Resnick, M. A. & Gordenin, D. A. Hypermutability of damaged single-strand DNA formed at double-strand breaks and uncapped telomeres in yeast Saccharomyces cerevisiae. PLoS Genet. 4, e1000264 (2008
35. Rhind, N. & Gilbert, D. M. DNA replication timing. Cold Spring Harb. Perspect. Biol. 5, a010132 (2013
36. Stamatoyannopoulos, J. A. What does our genome encode?. Genome Res. 22, 1602-1611 (2012
37. Thurman, R. E., Day, N., Noble, W. S. & Stamatoyannopoulos, J. A. Identification of higher-order functional domains in the human ENCODE regions. Genome Res. 17, 917-927 (2007
38. Liu, L., De, S. & Michor, F. DNA replication timing and higher-order nuclear organization determine single-nucleotide substitution patterns in cancer genomes. Nature Commun. 4, 1502 (2013
39. Polak, P. et al. Reduced local mutation density in regulatory DNA of cancer genomes is linked to DNA repair. Nature Biotech. 32, 71-75 (2014
40. Koren, A. et al. Differential relationship of DNA replication timing to different forms of human mutation and variation. Am. J. Hum. Genet. 91, 1033-1040 (2012
41. Stamatoyannopoulos, J. A. et al. Human mutation rate associated with DNA replication timing. Nature Genet. 41, 393-395 (2009
42. Hoang, M. L. et al. Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing. Sci. Transl. Med. 5, 197ra102 (2013
43. Pleasance, E. D. et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463, 191-196 (2010
44. Pleasance, E. D. et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463, 184-190 (2010
45. Poon, S. L. et al. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool. Sci. Transl. Med. 5, 197ra101 (2013
46. Schuster-Bockler, B. & Lehner, B. Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature 488, 504-507 (2012
47. Stratton, M. R. Exploring the genomes of cancer cells: progress and promise. Science 331, 1553-1558 (2011
48. Devarajan, K. Nonnegative matrix factorization: an analytical and interpretive tool in computational biology. PLoS Comput. Biol. 4, e1000029 (2008
49. Lee, D. D. & Seung, H. S. Learning the parts of objects by non-negative matrix factorization. Nature 401, 788-791 (1999
50. Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Campbell, P. J. & Stratton, M. R. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 3, 246-259 (2013
51. Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979-993 (2012
52. Jia, P., Pao, W. & Zhao, Z. Patterns and processes of somatic mutations in nine major cancers. BMC Med. Genom. 7, 11 (2014
53. Wang, J. et al. Evidence for mutation showers. Proc. Natl Acad. Sci. USA 104, 8403-8408 (2007
54. Chen, Z., Feng, J., Buzin, C. H. & Sommer, S. S. Epidemiology of doublet/multiplet mutations in lung cancers: evidence that a subset arises by chronocoordinate events. PLoS ONE 3, e3714 (2008
55. Chan, K., Resnick, M. A. & Gordenin, D. A. The choice of nucleotide inserted opposite abasic sites formed within chromosomal DNA reveals the polymerase activities participating in translesion DNA synthesis. DNA Repair 12, 878-889 (2013
56. Mimitou, E. P. & Symington, L. S. DNA end resection - unraveling the tail. DNA Repair 10, 344-348 (2011
57. Dewar, J. M. & Lydall, D. Similarities and differences between "uncapped" telomeres and DNA double-strand breaks. Chromosoma 121, 117-130 (2012
58. Saini, N. et al. Migrating bubble during break-induced replication drives conservative DNA synthesis. Nature 502, 389-392 (2013
59. Lopes, M., Foiani, M. & Sogo, J. M. Multiple mechanisms control chromosome integrity after replication fork uncoupling and restart at irreparable UV lesions. Mol. Cell 21, 15-27 (2006
60. Sogo, J. M., Lopes, M. & Foiani, M. Fork reversal and ssDNA accumulation at stalled replication forks owing to checkpoint defects. Science 297, 599-602 (2002
61. McInerney, P. & O'Donnell, M. Functional uncoupling of twin polymerases: mechanism of polymerase dissociation from a lagging-strand block. J. Biol. Chem. 279, 21543-21551 (2004
62. Yeeles, J. T., Poli, J., Marians, K. J. & Pasero, P. Rescuing stalled or damaged replication forks. Cold Spring Harb. Perspect. Biol. 5, a012815 (2013
63. Sakofsky, C. J. et al. Break-induced replication is a source of mutation clusters underlying kataegis. Cell Rep. 7, 1640-1648 (2014
64. Bartek, J., Lukas, J. & Bartkova, J. DNA damage response as an anti-cancer barrier: damage threshold and the concept of 'conditional haploinsufficiency'. Cell Cycle 6, 2344-2347 (2007
65. Costantino, L. et al. Break-induced replication repair of damaged forks induces genomic duplications in human cells. Science 343, 88-91 (2014
66. Chin, K. et al. In situ analyses of genome instability in breast cancer. Nature Genet. 36, 984-988 (2004
67. Vega, F. et al. Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes. Br. J. Haematol. 142, 216-226 (2008
68. Poncet, D. et al. Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B chronic lymphocytic leukemia. Blood 111, 2388-2391 (2008
69. Aguilera, A. & Garcia-Muse, T. R loops: from transcription byproducts to threats to genome stability. Mol. Cell 46, 115-124 (2012
70. Roberts, S. A. & Gordenin, D. A. Clustered and genome-wide transient mutagenesis in human cancers: Hypermutation without permanent mutators or loss of fitness. Bioessays 36, 382-393 (2014
71. Roberts, S. A. et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nature Genet. 45, 970-976 (2013
72. Rogozin, I. B., Pavlov, Y. I., Bebenek, K., Matsuda, T. & Kunkel, T. A. Somatic mutation hotspots correlate with DNA polymerase eta error spectrum. Nature Immunol. 2, 530-536 (2001
73. Neuberger, M. S. & Rada, C. Somatic hypermutation: activation-induced deaminase for C/G followed by polymerase eta for A/T. J. Exp. Med. 204, 7-10 (2007
74. Liu, M. & Schatz, D. G. Balancing AID and DNA repair during somatic hypermutation. Trends Immunol. 30, 173-181 (2009
75. Maul, R. W. & Gearhart, P. J. AID and somatic hypermutation. Adv. Immunol. 105, 159-191 (2010
76. Peled, J. U. et al. The biochemistry of somatic hypermutation. Annu. Rev. Immunol. 26, 481-511 (2008
77. Rogozin, I. B. & Diaz, M. Cutting edge: DGYW/WRCH is a better predictor of mutability at G:C bases in Ig hypermutation than the widely accepted RGYW/WRCY motif and probably reflects a two-step activation-induced cytidine deaminase-Triggered process. J. Immunol. 172, 3382-3384 (2004
78. Migliazza, A. et al. Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B cell lymphoma. Proc. Natl Acad. Sci. USA 92, 12520-12524 (1995
79. Pasqualucci, L. et al. Hypermutation of multiple proto-oncogenes in B cell diffuse large-cell lymphomas. Nature 412, 341-346 (2001
80. Bolli, N. et al. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nature Commun. 5, 2997 (2014
81. Puente, X. S. et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475, 101-105 (2011
82. Refsland, E. W. & Harris, R. S. The APOBEC3 family of retroelement restriction factors. Curr. Top. Microbiol. Immunol. 371, 1-27 (2013
83. Smith, H. C., Bennett, R. P., Kizilyer, A., McDougall, W. M. & Prohaska, K. M. Functions and regulation of the APOBEC family of proteins. Semin. Cell Dev. Biol. 23, 258-268 (2012
84. Gibbs, P. E. & Lawrence, C. W. Novel mutagenic properties of abasic sites in Saccharomyces cerevisiae. J. Mol. Biol. 251, 229-236 (1995
85. Gibbs, P. E., McDonald, J., Woodgate, R. & Lawrence, C. W. The relative roles in vivo of Saccharomyces cerevisiae Pol e, Pol ?, Rev1 protein and Pol32 in the bypass and mutation induction of an abasic site, T T (6 4) photoadduct and T T cis-syn cyclobutane dimer. Genetics 169, 575-582 (2005
86. Krokan, H. E. et al. Error-free versus mutagenic processing of genomic uracil-Relevance to cancer. DNA Repair 19, 38-47(2014
87. Pham, P., Chelico, L. & Goodman, M. F. DNA deaminases AID and APOBEC3G act processively on single-stranded DNA. DNA Repair 6, 689-692; author reply 693-694 (2007
88. Chelico, L., Pham, P., Calabrese, P. & Goodman, M. F. APOBEC3G DNA deaminase acts processively 3' ? 5' on single-stranded DNA. Nature Struct. Mol. Biol. 13, 392-399 (2006
89. Burns, M. B. et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494, 366-370 (2013
90. Burns, M. B., Temiz, N. A. & Harris, R. S. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nature Genet. 45, 977-983 (2013
91. Taylor, B. J. et al. DNA deaminases induce break-Associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. Elife 2, e00534 (2013
92. Kidd, J. M., Newman, T. L., Tuzun, E., Kaul, R. & Eichler, E. E. Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet. 3, e63 (2007
93. Long, J. et al. A common deletion in the APOBEC3 genes and breast cancer risk. J. Natl Cancer Inst. 105, 573-579 (2013
94. Xuan, D. et al. APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry. Carcinogenesis 34, 2240-2243 (2013
95. Zhang, T. et al. Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma. Hum. Mol. Genet. 22, 1262-1269 (2013
96. Nik-Zainal, S. et al. Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer. Nature Genet. 46, 487-491 (2014
97. Pfeifer, G. P. Mutagenesis at methylated CpG sequences. Curr. Top. Microbiol. Immunol. 301, 259-281 (2006
98. Visnes, T. et al. Uracil in DNA and its processing by different DNA glycosylases. Phil. Trans. R. Soc. B 364, 563-568 (2009
99. Antequera, F. Structure, function and evolution of CpG island promoters. Cell. Mol. Life Sci. 60, 1647-1658 (2003
100. Schmidt, S. et al. Hypermutable non-synonymous sites are under stronger negative selection. PLoS Genet. 4, e1000281 (2008
101. World Health Organisation. A Review of Human Carcinogens: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 100D, 7-303 (World Health Organisation, 2012
102. Plosky, B. S. & Woodgate, R. Switching from high-fidelity replicases to low-fidelity lesion-bypass polymerases. Curr. Opin. Genet. Dev. 14, 113-119 (2004
103. Sale, J. E. Translesion DNA synthesis and mutagenesis in eukaryotes. Cold Spring Harb. Perspect. Biol. 5, a012708 (2013
104. Ikehata, H. & Ono, T. The mechanisms of UV mutagenesis. J. Radiat. Res. 52, 115-125 (2011
105. Berger, M. F. et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 485, 502-506 (2012
106. Breen, A. P. & Murphy, J. A. Reactions of oxyl radicals with DNA. Free Radic. Biol. Med. 18, 1033-1077 (1995
107. Cadet, J. & Wagner, J. R. DNA base damage by reactive oxygen species, oxidizing agents, and UV radiation.Cold Spring Harb. Perspect. Biol. 5, a012559 (2013
108. Evans, M. D., Dizdaroglu, M. & Cooke, M. S. Oxidative DNA damage and disease: induction, repair and significance. Mutat. Res. 567, 1-61 (2004
109. Degtyareva, N. P. et al. Oxidative stress-induced mutagenesis in single-strand DNA occurs primarily at cytosines and is DNA polymerase ?-dependent only for adenines and guanines. Nucleic Acids Res. 41, 8995-9005 (2013
110. Moraes, E. C., Keyse, S. M. & Tyrrell, R. M. Mutagenesis by hydrogen peroxide treatment of mammalian cells: a molecular analysis. Carcinogenesis 11, 283-293 (1990
111. Tkeshelashvili, L. K., McBride, T., Spence, K. & Loeb, L. A. Mutation spectrum of copper-induced DNA damage. J. Biol. Chem. 266, 6401-6406 (1991
112. Bacolla, A., Cooper, D. N. & Vasquez, K. M. Mechanisms of base substitution mutagenesis in cancer genomes. Genes 5, 108-146 (2014
113. Bacolla, A. et al. Guanine holes are prominent targets for mutation in cancer and inherited disease. PLoS Genet. 9, e1003816 (2013
114. DeMarini, D. M. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat. Res. 567, 447-474 (2004
115. Pfeifer, G. P. et al. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-Associated cancers. Oncogene 21, 7435-7451 (2002
116. Govindan, R. et al. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 150, 1121-1134 (2012
117. Imielinski, M. et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150, 1107-1120 (2012
118. Lee, W. et al. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 465, 473-477 (2010
119. Bodell, W. J., Gaikwad, N. W., Miller, D. & Berger, M. S. Formation of DNA adducts and induction of lacI mutations in Big Blue Rat 2 cells treated with temozolomide: implications for the treatment of low-grade adult and pediatric brain tumors. Cancer Epidemiol. Biomarkers Prev. 12, 545-551 (2003
120. Stojic, L., Brun, R. & Jiricny, J. Mismatch repair and DNA damage signalling. DNA Repair 3, 1091-1101 (2004
121. Tomita-Mitchell, A. et al. Mismatch repair deficient human cells: spontaneous and MNNG-induced mutational spectra in the HPRT gene. Mutat. Res. 450, 125-138 (2000
122. Cahill, D. P. et al. Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment. Clin. Cancer Res. 13, 2038-2045 (2007
123. Hunter, C. et al. A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. Cancer Res. 66, 3987-3991 (2006
124. Moen, E. L., Stark, A. L., Zhang, W., Dolan, M. E. & Godley, L. A. The role of gene body cytosine modifications in MGMT expression and sensitivity to temozolomide. Mol. Cancer Ther. (2014
125. Zhang, J. et al. Certain imidazotetrazines escape O6 methylguanine-DNA methyltransferase and mismatch repair. Oncology 80, 195-207 (2011
126. Johnson, B. E. et al. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343, 189-193 (2014
127. Arlt, V. M., Stiborova, M. & Schmeiser, H. H. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 17, 265-277 (2002
128. National Toxicology Program. Aristolochic acids. Rep. Carcinog. 12, 45-49 (2011
129. Sidorenko, V. S. et al. Lack of recognition by global-genome nucleotide excision repair accounts for the high mutagenicity and persistence of aristolactam- DNA adducts. Nucleic Acids Res. 40, 2494-2505 (2012
130. Chen, C. H. et al. Aristolochic acid-Associated urothelial cancer in Taiwan. Proc. Natl Acad. Sci. USA 109, 8241-8246 (2012
131. Hollstein, M., Moriya, M., Grollman, A. P. & Olivier, M. Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid. Mutat. Res. 753, 41-49 (2013
132. Kunkel, T. A. & Bebenek, K. DNA replication fidelity. Annu. Rev. Biochem. 69, 497-529 (2000
133. Kunkel, T. A. & Erie, D. A. DNA mismatch repair. Annu. Rev. Biochem. 74, 681-710 (2005
134. Shcherbakova, P. V. & Fijalkowska, I. J. Translesion synthesis DNA polymerases and control of genome stability. Front. Biosci. 11, 2496-2517 (2006
135. Vilar, E. & Gruber, S. B. Microsatellite instability in colorectal cancer-The stable evidence. Nature Rev. Clin. Oncol. 7, 153-162 (2010
136. Kim, T. M., Laird, P. W. & Park, P. J. The landscape of microsatellite instability in colorectal and endometrial cancer genomes. Cell 155, 858-868 (2013
137. Briggs, S. & Tomlinson, I. Germline and somatic polymerase epsilon and delta mutations define a new class of hypermutated colorectal and endometrial cancers. J. Pathol. 230, 148-153 (2013
138. Palles, C. et al. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nature Genet. 45, 136-144 (2013
139. Valle, L. et al. New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis. Hum. Mol. Genet. 23, 3506-3512 (2014
140. Zou, Y. et al. Frequent POLE1 p. S297F mutation in Chinese patients with ovarian endometrioid carcinoma. Mutat. Res. 761, 49-52 (2014
141. Nick McElhinny, S. A., Gordenin, D. A., Stith, C. M., Burgers, P. M. & Kunkel, T. A. Division of labor at the eukaryotic replication fork. Mol. Cell 30, 137-144 (2008
142. Cancer Genome Atlas Research Network. Integrated genomic characterization of endometrial carcinoma. Nature 497, 67-73 (2013
143. Donehower, L. A. et al. MLH1 silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes. J. Pathol. 229, 99-110 (2013
144. Matsuda, T., Bebenek, K., Masutani, C., Hanaoka, F. & Kunkel, T. A. Low fidelity DNA synthesis by human DNA polymerase-e. Nature 404, 1011-1013 (2000
145. Machida, K. et al. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc. Natl Acad. Sci. USA 101, 4262-4267 (2004
146. Totoki, Y. et al. High-resolution characterization of a hepatocellular carcinoma genome. Nature Genet. 43, 464-469 (2011
147. Sotillo, R. et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11, 9-23 (2007
148. Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nature Biotech. 30, 413-421 (2012
149. Davoli, T. et al. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell 155, 948-962 (2013
150. Ciriello, G. et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genet. 45, 1127-1133 (2013
151. Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27-40 (2011
152. Liu, P. et al. Chromosome catastrophes involve replication mechanisms generating complex genomic rearrangements. Cell 146, 889-903 (2011
153. Lee, R. S. et al. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J. Clin. Invest. 122, 2983-2988 (2012
154. Parsons, D. W. et al. The genetic landscape of the childhood cancer medulloblastoma. Science 331, 435-439 (2011
155. Crompton, B. D. et al. The genomic landscape of pediatric ewing sarcoma. Cancer Discov. http://dx.doi.org/10.1158/2159-8290.CD-13-1037 (2014
156. Lawrence, M. S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495-501 (2014
157. Papaemmanuil, E. et al. RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6 RUNX1 acute lymphoblastic leukemia. Nature Genet. 46, 116-125 (2014
158. Robbiani, D. F. et al. AID is required for the chromosomal breaks in c myc that lead to c myc/IgH translocations. Cell 135, 1028-1038 (2008
159. Dorsett, Y. et al. A role for AID in chromosome translocations between c myc and the IgH variable region. J. Exp. Med. 204, 2225-2232 (2007
160. Burrell, R. A. & Swanton, C. The evolution of the unstable cancer genome. Curr. Opin. Genet. Dev. 24, 61-67 (2013
161. Henderson, S., Chakravarthy, A., Su, X., Boshoff, C. & Fenton, T. R. APOBEC-Mediated Cytosine Deamination Links PIK3CA Helical Domain Mutations to Human Papillomavirus-Driven Tumor Development. Cell Rep. 7, 1833-1841 (2014
162. Viros, A. et al. Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53. Nature 511, 478-482 (2014
163. Douville, C. et al. CRAVAT: cancer-related analysis of variants toolkit. Bioinformatics 29, 647-648 (2013
164. Dulak, A. M. et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nature Genet. 45, 478-486 (2013
165. Jager, N. et al. Hypermutation of the inactive X chromosome is a frequent event in cancer. Cell 155, 567-581 (2013
166. Kumar, A. et al. Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers. Proc. Natl Acad. Sci. USA 108, 17087-17092 (2011
167. Baca, S. C. et al. Punctuated evolution of prostate cancer genomes. Cell 153, 666-677 (2013
168. Poon, S., McPherson, J., Tan, P., Teh, B. & Rozen, S. Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention. Genome Med. 6, 24 (2014
169. Nik-Zainal, S. et al. The life history of 21 breast cancers. Cell 149, 994-1007 (2012
170. Ciccia, A. & Elledge, S. J. The DNA damage response: making it safe to play with knives. Mol. Cell 40, 179-204 (2010